Use of SBA-15 for furosemide oral delivery enhancement

European Journal of Pharmaceutical Sciences

Volumn 46, Issue 1-2, 2012, Pages 43-48

  Ambrogi, Valeria ^a   Perioli, Luana ^a   Pagano, Cinzia ^a   Marmottini, Fabio ^a   Ricci, Maurizio ^a   Sagnella, Anna ^a   Rossi, Carlo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

BCS; Dissolution; Furosemide; SBA 15; Supersaturation

Indexed keywords

DRUG CARRIER; FUROSEMIDE; NITROGEN; SBA 15 SILICATE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; CONTROLLED STUDY; DESORPTION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; THERMOGRAVIMETRY; X RAY POWDER DIFFRACTION;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; DIURETICS; DRUG CARRIERS; DRUG STABILITY; FUROSEMIDE; HUMANS; HUMIDITY; SILICON DIOXIDE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TEMPERATURE; THERMOGRAVIMETRY; X-RAY DIFFRACTION;

EID: 84859209680     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.02.004     Document Type: Article

References (25)

1. Ambrogi, V., Perioli, L., Pagano, C., Marmottini, F., Moretti, M., Mizzi, F., Rossi, C., 2010. Econazole nitrate-loaded MCM-41 for an antifungal topical powder formulation. J. Pharm. Sci. 99, 4738-4745.
2. Ambrogi, V., Perioli, L., Pagano, C., Latterini, L., Marmottini, F., Ricci, M., Rossi, C., 2011. MCM-41 for furosemide dissolution improvement. Microporous Mesoporous Mater. 147, 343-349.
3. Barrett, E.P., Joyner, L.G., Halenda, P.P., 1951. The determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isotherms. J. Am. Chem. Soc. 73, 373-380.
4. Beyers, H., Malan, S.F., van der Watt, J.G., de Villiers, M.M., 2000. Structure-solubility relationship and thermal decomposition of furosemide. Drug Dev. Ind. Pharm. 26, 1077-1083.
5. Brunauer, S., Emmet, P.H., Teller, E., 1938. Adsorption of gases in multimolecular layers. J. Am. Chem. Soc. 60, 309-319.
6. Cassiers, K., Linssen, T., Mathieu, M., Benjelloun, M., Schrijnemakers, K., Van Der Voort, P., Cool, P., Vansant, E.F., 2002. A detailed study of thermal, hydrothermal, and mechanical stabilities of a wide range of surfactant assembled mesoporous silicas. Chem. Mater. 14, 2317-2324.
7. Celera, E.B., Kruk, M., Zuzek, Y., Jaroniec, M., 2006. Hydrothermal stability of SBA-15 and related ordered mesoporous silicas with plugged pores. J. Mater. Chem. 16, 2824-2833. (Pubitemid 43993800)
8. Charnay, C., Bégu, S., Tourné-Péteilh, C., Nicole, L., Lerner, D.A., Devoisselle, J.M., 2004. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur. J. Pharm. Biopharm. 57, 533-540. (Pubitemid 38490572)
9. Chungi, V.S., Dittert, L.W., Smith, R.B., 1979. Gastrointestinal sites of furosemide absorption in rats. Int. J. Pharm. 4, 27-38. (Pubitemid 10188478)
10. Custodio, J.M., Wu, C., Benet, L.Z., 2008. Predicting drug disposition, absorption/ elimination/transporter interplay and the role of food on drug absorption. Adv. Drug Deliv. Rev. 60, 717-733.
11. Davis, S.S., 2005. Formulation strategies for absorption windows. Drug Discovery Today 1, 249-257. (Pubitemid 40222218)
12. EMEA, 2003. Guideline on stability testing: stability testing of existing active substances and related finished products, CPMP/QWP/122/02, rev 1.
13. Fulvio, P.F., Pikus, S., Jaroniec, M., 2005. Short-time synthesis of SBA-15 using various silica sources. J. Colloid Interface Sci. 287, 717-720. (Pubitemid 40755510)
14. Granero, G.E., Longhi, M.R., Mora, M.J., Junginger, H.E., Midha, K.K., Shah, V.P., Stavchansky, S., Dressman, J.B., Barends, D.M., 2010. Biowaiver monographs for immediate release solid oral dosage forms: furosemide. J. Pharm. Sci. 99, 2544-2556.
15. Kaukonen, A.M., Laitinen, L., Salonen, J., Tuura, J., Heikkilä, T., Limnell, T., Hirvonen, J., Lehto, V.-P., 2007. Enhanced invitro permeation of furosemide loaded into thermally carbonized mesoporous silicon (TCPSi) microparticles. Eur. J. Pharm. Biopharm. 66, 348-356. (Pubitemid 46756223)
16. Ma, Y., Qi, L., Ma, J., Wu, Y., Liu, O., Cheng, H., 2003. Large-pore mesoporous silica spheres: synthesis and application in HPLC. Colloids Surf. A 229, 1-8. (Pubitemid 37463537)
17. Mellaerts, R., Jammaer, J.A.G., Van Speybroeck, M., Chen, H., Van Humbeeck, J., Augustijns, P., Van den Mooter, G., Martens, J.A., 2008. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen. Langmuir 24, 8651-8659.
18. Price, R.R., Gaber, B.P., Lvov, Y., 2001. In vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dineculeotide from halloysite; a cylindrical mineral. J. Microencapsul. 18, 713-722. (Pubitemid 32998320)
19. Qu, F., Zhu, G., Lin, H., Zhang, W., Sun, J., Li, S., Qiu, S., 2006. A controlled release of ibuprofen by systematically tailoring the morphology of mesoporous silica materials. J. Solid State Chem. 179, 2027-2035. (Pubitemid 43867553)
20. Salonen, J., Laitinen, L., Kaukonen, A.M., Tuura, J., Björkqvist, M., Heikkilä, T., Vähä- Heikkilä, K., Hirvonen, J., Lehto, V.-P., 2005. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J. Controlled Release 108, 362-374. (Pubitemid 41608668)
21. Sharma, S., Sher, P., Badve, S., Pawar, A.P., 2005. Adsorption of meloxicam on porous calcium silicate: characterization and tablet formulation. AAPS PharmSciTech 6, E618-E625 Article 76 (http://www.aapspharmscitech.org).
22. Shin, S.-C., Kim, J., 2003. Physicochemical characterization of solid dispersion of furosemide with TPGS. Int. J. Pharm. 251, 79-84. (Pubitemid 36071462)
23. Veerabadran, N.G., Price, R.R., Lvov, Y.M., 2007. Clay nanotubes for encapsulation and sustained release of drugs. NANO: Brief Reports and Reviews 2, 115-120.
24. Wang, S., 2009. Ordered mesoporous materials for drug delivery. Microporous Mesoporous Mater. 117, 1-9.
25. Yu, L.X., Wang, J.T., Hussain, A.S., 2002. Evaluation of USP apparatus 3 for dissolution testing of immediate-release products. AAPS PharmSci 4, 1-5 (http:// www.pharmsci.org).